The rebrand marks a shift from building a brain-computer interface to building the evidence base for neuromodulation itself, with the Forest 1 ultrasound system repositioned as a measurement instrument rather than a product. As a nonprofit Focused Research Organization scoped to a problem with no commercial roadmap, Arbor sits outside the venture-backed cohort around it on this map.